7be0: Difference between revisions
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
==X-ray structure of Hen Egg White Lysozyme with dirhodium tetraacetate (2)== | ==X-ray structure of Hen Egg White Lysozyme with dirhodium tetraacetate (2)== | ||
<StructureSection load='7be0' size='340' side='right'caption='[[7be0]]' scene=''> | <StructureSection load='7be0' size='340' side='right'caption='[[7be0]], [[Resolution|resolution]] 1.62Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7BE0 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7BE0 FirstGlance]. <br> | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7BE0 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7BE0 FirstGlance]. <br> | ||
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7be0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7be0 OCA], [https://pdbe.org/7be0 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7be0 RCSB], [https://www.ebi.ac.uk/pdbsum/7be0 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7be0 ProSAT]</span></td></tr> | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.62Å</td></tr> | ||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=NO3:NITRATE+ION'>NO3</scene>, <scene name='pdbligand=RH:RHODIUM'>RH</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7be0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7be0 OCA], [https://pdbe.org/7be0 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7be0 RCSB], [https://www.ebi.ac.uk/pdbsum/7be0 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7be0 ProSAT]</span></td></tr> | |||
</table> | </table> | ||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
The structures of the adducts formed upon reaction of the cytotoxic paddlewheel dirhodium complex [Rh2(mu-O2CCH3)4] with the model protein hen egg white lysozyme (HEWL) under different experimental conditions are reported. Results indicate that [Rh2(mu-O2CCH3)4] extensively reacts with HEWL:it in part breaks down, at variance with what happens in reactions with other proteins. A Rh center coordinates the side chains of Arg14 and His15. Dimeric Rh-Rh units with Rh-Rh distances between 2.3 and 2.5 A are bound to the side chains of Asp18, Asp101, Asn93, and Lys96, while a dirhodium unit with a Rh-Rh distance of 3.2-3.4 A binds the C-terminal carboxylate and the side chain of Lys13 at the interface between two symmetry-related molecules. An additional monometallic fragment binds the side chain of Lys33. These data, which are supported by replicated structural determinations, shed light on the reactivity of dirhodium tetracarboxylates with proteins, providing useful information for the design of new Rh-containing biomaterials with an array of potential applications in the field of catalysis or of medicinal chemistry and valuable insight into the mechanism of action of these potential anticancer agents. | |||
Unusual Structural Features in the Adduct of Dirhodium Tetraacetate with Lysozyme.,Loreto D, Ferraro G, Merlino A Int J Mol Sci. 2021 Feb 2;22(3). pii: ijms22031496. doi: 10.3390/ijms22031496. PMID:33540880<ref>PMID:33540880</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
</div> | |||
<div class="pdbe-citations 7be0" style="background-color:#fffaf0;"></div> | |||
==See Also== | |||
*[[Lysozyme 3D structures|Lysozyme 3D structures]] | |||
== References == | |||
<references/> | |||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> |
Latest revision as of 11:36, 17 October 2024
X-ray structure of Hen Egg White Lysozyme with dirhodium tetraacetate (2)X-ray structure of Hen Egg White Lysozyme with dirhodium tetraacetate (2)
Structural highlights
Publication Abstract from PubMedThe structures of the adducts formed upon reaction of the cytotoxic paddlewheel dirhodium complex [Rh2(mu-O2CCH3)4] with the model protein hen egg white lysozyme (HEWL) under different experimental conditions are reported. Results indicate that [Rh2(mu-O2CCH3)4] extensively reacts with HEWL:it in part breaks down, at variance with what happens in reactions with other proteins. A Rh center coordinates the side chains of Arg14 and His15. Dimeric Rh-Rh units with Rh-Rh distances between 2.3 and 2.5 A are bound to the side chains of Asp18, Asp101, Asn93, and Lys96, while a dirhodium unit with a Rh-Rh distance of 3.2-3.4 A binds the C-terminal carboxylate and the side chain of Lys13 at the interface between two symmetry-related molecules. An additional monometallic fragment binds the side chain of Lys33. These data, which are supported by replicated structural determinations, shed light on the reactivity of dirhodium tetracarboxylates with proteins, providing useful information for the design of new Rh-containing biomaterials with an array of potential applications in the field of catalysis or of medicinal chemistry and valuable insight into the mechanism of action of these potential anticancer agents. Unusual Structural Features in the Adduct of Dirhodium Tetraacetate with Lysozyme.,Loreto D, Ferraro G, Merlino A Int J Mol Sci. 2021 Feb 2;22(3). pii: ijms22031496. doi: 10.3390/ijms22031496. PMID:33540880[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
|